Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung

Non-squamous Non-small Cell Lung Cancer

Mesothelioma, Malignant

Carcinoma, Non-Small-Cell Lung

Kidney Neoplasms, Lung Neoplasms, Melanoma

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Advanced Non-squamous Non-Small-Cell Lung Cancer

Non-small Cell Lung Cancer Metastatic

Non-squamous Non-small Cell Lung Cancer

Pleural Effusion, Malignant

EGFR Positive Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Thoracic Neoplasms

Lung Neoplasms, Surgical Wound Infection, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Adenocarcinoma of Lung

Non-squamous Cell Non-small Cell Lung Cancer

Pleural Effusion, Malignant

Carcinoma, Non-Small-Cell Lung

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Non-small Cell Lung Cancer Metastatic

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Pleural Effusion, Malignant

Carcinoma, Non-Small-Cell Lung

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Untreated Advanced Non-Small Cell Lung Cancer

Clinical Trials

Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy

Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

BEVERLY

MiST

Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment

Microbiome Immunotherapy Toxicity and Response Evaluation

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

SPBPDC

BETTER

Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC

A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion

AvaTa

Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer

Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC

ATTRACT

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

The Effects of Preoperative Bevacizumab on Perioperative Complications

BELLA

Clinical Trial in Chinese Healthy Volunteers of GB222

Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene

To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer

Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer

Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC

BRILLIANT

A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer

Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable Disease

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer

Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance

Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion

Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC

VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer

Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer

Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)